SCHEMBL4775877

SCHEMBL4775877

Cc1ccnc(-c2nc(NCCc3c[nH]c4ccccc34)cc(-c3cccnc3)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.56
USP2 O75604 5/20 0.56
CYP1A2 P05177 5/20 0.56
CYP2D6 P10635 5/20 0.56
CYP2C19 P33261 5/20 0.56
CLK4 Q9HAZ1 5/20 0.56
CYP2C9 P11712 5/20 0.56
CDK4 P11802 2/20 0.54
CCND1 P24385 2/20 0.54
GBA1 P04062 1/20 0.54
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 2/20 0.53
ALOX15 P16050 2/20 0.53
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
GAA P10253 1/20 0.49
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771731 0.90 GBA1 (0.54) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL3962080 0.89 CDK4 (0.58) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2241055 0.87 CYP3A4 (0.51) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2241071 0.87 CYP3A4 (0.57) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2240068 0.87 CDK4 (0.55) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2241708 0.86 GBA1 (0.57) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2237738 0.84 GBA1 (0.63) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2240377 0.83 GBA1 (0.47) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL3715061 0.82 GBA1 (0.55) CYP3A4USP2CYP1A2CYP2D6CYP2C19
SCHEMBL2238361 0.82 PTGDR (0.49) CYP3A4USP2CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed